BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 24602839)

  • 1. Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis.
    Tsai CY; Wang CS; Tsai MM; Chi HC; Cheng WL; Tseng YH; Chen CY; Lin CD; Wu JI; Wang LH; Lin KH
    Clin Cancer Res; 2014 May; 20(9):2276-88. PubMed ID: 24602839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CXCR1 and 2 expressions with gastric cancer metastasis in ex vivo and tumor cell invasion in vitro.
    Li Z; Wang Y; Dong S; Ge C; Xiao Y; Li R; Ma X; Xue Y; Zhang Q; Lv J; Tan Q; Zhu Z; Song X; Tan J
    Cytokine; 2014 Sep; 69(1):6-13. PubMed ID: 25022956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krüppel-like factor 4 negatively regulates β-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer.
    Zhang N; Zhang J; Shuai L; Zha L; He M; Huang Z; Wang Z
    Int J Oncol; 2012 Jun; 40(6):2038-48. PubMed ID: 22407433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.
    Zhang C; Tian W; Meng L; Qu L; Shou C
    J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer.
    Bie Q; Sun C; Gong A; Li C; Su Z; Zheng D; Ji X; Wu Y; Guo Q; Wang S; Xu H
    Sci Rep; 2016 May; 6():25447. PubMed ID: 27146881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo.
    Zhang L; Kim S; Ding W; Tong Y; Zhang X; Pan M; Chen S
    Drug Des Devel Ther; 2015; 9():5579-90. PubMed ID: 26487802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
    Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
    Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9.
    Huang Q; Lan F; Wang X; Yu Y; Ouyang X; Zheng F; Han J; Lin Y; Xie Y; Xie F; Liu W; Yang X; Wang H; Dong L; Wang L; Tan J
    Mol Cancer; 2014 Jan; 13():18. PubMed ID: 24479681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression.
    Zeng Q; Li S; Zhou Y; Ou W; Cai X; Zhang L; Huang W; Huang L; Wang Q
    Cytokine; 2014 Jan; 65(1):24-32. PubMed ID: 24140068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DJ-1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway.
    Zhu ZM; Li ZR; Huang Y; Yu HH; Huang XS; Yan YF; Shao JH; Chen HP
    Oncol Rep; 2014 Mar; 31(3):1489-97. PubMed ID: 24398929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
    Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML
    Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer.
    Gao P; Xing AY; Zhou GY; Zhang TG; Zhang JP; Gao C; Li H; Shi DB
    Oncogene; 2013 Jan; 32(4):491-501. PubMed ID: 22370644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production.
    Zhou H; Wu J; Wang T; Zhang X; Liu D
    Biomed Pharmacother; 2016 Aug; 82():479-88. PubMed ID: 27470388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
    Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
    Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin β1/FAK/AKT signaling.
    Wang Z; Wang Z; Li G; Wu H; Sun K; Chen J; Feng Y; Chen C; Cai S; Xu J; He Y
    Cancer Lett; 2017 Jan; 385():28-38. PubMed ID: 27832972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression.
    Chang YC; Chan YC; Chang WM; Lin YF; Yang CJ; Su CY; Huang MS; Wu ATH; Hsiao M
    Cancer Lett; 2017 Sep; 403():28-36. PubMed ID: 28610954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK5RAP3 suppresses Wnt/β-catenin signaling by inhibiting AKT phosphorylation in gastric cancer.
    Zheng CH; Wang JB; Lin MQ; Zhang PY; Liu LC; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Xie JW; Li P; Huang CM
    J Exp Clin Cancer Res; 2018 Mar; 37(1):59. PubMed ID: 29540196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.
    Lee BL; Kim WH; Jung J; Cho SJ; Park JW; Kim J; Chung HY; Chang MS; Nam SY
    Carcinogenesis; 2008 Jan; 29(1):44-51. PubMed ID: 17984117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway.
    Zhou Q; Wang X; Yu Z; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
    Oncogene; 2017 Mar; 36(13):1873-1886. PubMed ID: 27694893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.